4Front Ventures Corp
4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. It engages in the cultivation, manufacturing, distribution, and retail of cannabis and cannabis derived goods in Illinois and Massachusetts, providing integrated supply chain to serve medical and recreational markets. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix… Read more
4Front Ventures Corp - Asset Resilience Ratio
4Front Ventures Corp (FFNTF) has an Asset Resilience Ratio of 1.91% as of September 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2018)
This chart shows how 4Front Ventures Corp's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down 4Front Ventures Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $6.54 Million | 1.91% |
| Total Liquid Assets | $6.54 Million | 1.91% |
Asset Resilience Insights
- Limited Liquidity: 4Front Ventures Corp maintains only 1.91% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
4Front Ventures Corp Industry Peers by Asset Resilience Ratio
Compare 4Front Ventures Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for 4Front Ventures Corp (2017–2018)
The table below shows the annual Asset Resilience Ratio data for 4Front Ventures Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-12-31 | 0.00% | $0.00 | $62.52 Million | -- |
| 2018-04-30 | 0.00% | $0.00 | $47.10 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $31.78 Million | -- |